Market Sector Glaxosmith Kline (GSK) : Report
Added on 2020-07-23
19 Pages3398 Words63 Views
CM Project
Table of Contents4.0 INDUSTRY ANALYSIS..........................................................................................................14.1 Market sector....................................................................................................................14.2 Competitors......................................................................................................................34.3 Strategic alliances.............................................................................................................55.0 MARKET ANALYSIS..............................................................................................................55.1 Market capitalization........................................................................................................65.2 Market segmentation........................................................................................................96.0 PERFORMANCE....................................................................................................................116.1 Earnings per share..........................................................................................................116.2 Share price......................................................................................................................126.3 Share price history..........................................................................................................136.4 Shares outstanding..........................................................................................................146.5 Debentures and other loans outstanding.........................................................................15REFERENCES..............................................................................................................................17
4.0 INDUSTRY ANALYSIS 4.1 Market sector Glaxosmith Kline (GSK) is a UK based pharmaceutical company that is headquartered inBrentford, London. It was established by the merger of SmithKline Beecham and GlaxoWellcome in the year 2000. It is primary listed on the London Stock Exchange with constituentsof FTSE 100 Index while secondary listing is on New York Stock Exchange (NYSE). It operatesin pharmaceutical industry of UK which mission is to provide qualify life to all so that peoplefeel better and live a healthier life. It operates in three segment; pharmaceutical, vaccines andconsumer healthcare business with an employee portfolio of 99,300. (GSK Fortune ranking, 2017)In world top 5000, it is ranked at 273position. Over the past few decade, the sector showsa consistent trade surplus worth 1.1 GBP billion annually (Pharmaceutical trade in UK, 2014).GSK's minimum and maximum market cap was reported to US $93.82 bn and 129.6 bn (see inmarket capitalization).1
(Source: Pharmaceutical trade in UK, 2014)As per the figure presented above, it is clearly visualized that sector is generating positivesurplus by having large export volume over import which is a clear indication of good progress. (Source: Pharmaceutical trade in UK, 2014)There are number of pharmaceutical companies who are contributing a great percentageto the UK economy which is comparatively larger than other high-tech industries. Above2
End of preview
Want to access all the pages? Upload your documents or become a member.